4-((1r,4r)-4-Ethylcyclohexyl)benzoic acid, 95.0%, 5g

[5-(methoxymethyl)-1,2-oxazol-3-yl]methanol, 98%, 250mg

4-(4-Bromo-phenyl)-3-sulfamoyl-5-trifluoromethyl-thiophene-2-carboxylic acid methyl ester, 95.0%, 1g

4,4'-(3',4',5',6'-Tetrakis(4-(pyridin-4-yl)phenyl)-[1,1':2',1''-terphenyl]-4,4''-diyl)dipyridine, 98%, 1g

2-hydroxy-3-nitrobenzonitrile, 95.0%, 1g

[2,2'-Bipyridine]-4,4'-diamine, 95.0%, 5g

Marking tape ROTI®Tape Core - 76.2 mm, width 13.0 mm, red, 1 Roll

5,7-Dichloro-3-isopropylpyrazolo[1,5-a]pyrimidine, 97%, 50g

6-Bromo-3-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine, 1g

(5-{[(tert-butoxy)carbonyl]amino}pentyl)(diazyn-1-ium-1-yl)azanide, 98%, 250mg

Dialysis membrane Spectra/Por® 7 MWCO 25,000 (opaque), 34 mm, 1 Piece(s)

3-Bromo-6-chloro-2-fluoroaniline, 97%, 100g

(3S)-3-(4-HYDROXYPHENYL)-4-HEXYNOIC ACID, 95.0%, 100mg